← 產業報告目錄

Digital Insomnia Therapeutics Market Size, Share & Trends Analysis Report byType (Sleep Tracking Apps. Relaxation and Meditation Apps, CBT-I, Wearable Devices), Distribution Channel (Mobile App Stores, Healthcare Providers and Clinics, and Other Distribution Channels), Region And Segment Forecasts, 2024-2031

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-15頁數 180報告編號 INSIGHTACE-a6cf7e360c

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

The Digital Insomnia Therapeutics Market on a global scale was estimated at USD 3.35 billion in 2023 and is projected to attain USD 5.16 billion by 2031, with a projected CAGR of 5.6% between 2024 and 2031. Digital Insomnia Therapeutics covers evidence-based treatments that include software, applications, and programmes for the diagnosrepresents and treatment of physical, mental, and behavioral disorders. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Digital Insomnia Therapeutic Market Snapshot Chapter 4. Global Digital Insomnia Therapeutic Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis of Metaverse Industry 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact on Metaverse Industry Chapter 5. Market Segmentation 1: By Distribution Channel Estimates & Trend Analysis 5.1. By Distribution Channel & Market Share, 2023-2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Distribution Channel: 5.2.1. Hospital Pharmacies 5.2.2. Retail Pharmacies 5.2.3. Other Distribution Channels Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis 6.1. By Type & Market Share, 2023-2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following Type Type: 6.2.1. Sleep Tracking Apps 6.2.2. Relaxation and Meditation Apps 6.2.3. CBT-I 6.2.4. Wearable Devices 6.2.5. Others Chapter 7. Digital Insomnia Therapeutic Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2023-2031 7.1.2. North America Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by Type, 2023-2031 7.1.3. North America Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by country, 2023-2031 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe Digital Insomnia Therapeutic Market revenue (US$ Million) by By Distribution Channel, 2023-2031 7.2.2. Europe Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by Type, 2023-2031 7.2.3. Europe Digital Insomnia Therapeutic Market revenue (US$ Million) by country, 2023-2031 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.3.5. Spain 7.2.3.6. UK 7.2.3.7. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Digital Insomnia Therapeutic Market revenue (US$ Million) by By Distribution Channel, 2023-2031 7.3.2. Asia Pacific Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by Type, 2023-2031 7.3.3. Asia Pacific Digital Insomnia Therapeutic Market revenue (US$ Million) by country, 2023-2031 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America Digital Insomnia Therapeutic Market revenue (US$ Million) by By Distribution Channel, 2023-2031 7.4.2. Latin America Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by Type, 2023-2031 7.4.3. Latin America Digital Insomnia Therapeutic Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. Middle East & Africa 7.5.1. Middle East & Africa Digital Insomnia Therapeutic Market revenue (US$ Million) by By Distribution Channel, (US$ Million) 7.5.2. Middle East & Africa Digital Insomnia Therapeutic Market revenue (US$ Million) estimates and forecasts by Type, 2023-2031 7.5.3. Middle East & Africa Digital Insomnia Therapeutic Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.5.3.1. South Africa 7.5.3.2. GCC Countries 7.5.3.3. Rest of MEA Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Headspace Inc. 8.2.2. Big Health 8.2.3. Calm 8.2.4. Nox Health 8.2.5. Pear Therapeutics Inc. 8.2.6. OPTT Inc. 8.2.7. SilverCloud 8.2.8. Curv Health 8.2.9. Bodymatter, Inc. 8.2.10. PrimeNap

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們